Infectious Agents and Cancer

unofficial impact factor 2.33

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Open Access Oral presentation

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

GM Clifford1*, M Rickenbach2, S Franceschi1 and the Swiss HIV Cohort Study

  • * Corresponding author: GM Clifford

Author Affiliations

1 International Agency for Research on Cancer, Lyon, France

2 Coordination and Data Center, Swiss HIV Cohort Study, Lausanne, Switzerland

For all author emails, please log on.

Infectious Agents and Cancer 2009, 4(Suppl 2):O6 doi:10.1186/1750-9378-4-S2-O6

Published: 17 June 2009

First paragraph (this article has no abstract)

To investigate HIV-related immunodeficiency as a risk factor for hepatocellular carcinoma (HCC) among persons infected with HIV, whilst controlling for the effect of frequent co-infection with hepatitis C and hepatitis B viruses.